laurence.jocaille_120

About laurence.jocaille_120

This author has not yet filled in any details.
So far laurence.jocaille_120 has created 393 blog entries.

Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort

2021-07-29T22:37:51+02:00

Schuil H, Derks M, Liefers GJ, Portielje J, van de Velde C, Syed B, Green A, Ellis I, Cheung KL, Bastiaannet E. J Geriatr Oncol. 2018 May 18. pii: S1879-4068(17)30286-2. doi: 10.1016/j.jgo.2018.05.004. [Epub ahead of print]

Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort2021-07-29T22:37:51+02:00

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study

2021-07-29T22:37:51+02:00

Westley T, Syrowatka A, Henault D, Rho YS, Khazoom F, Chang SL, Tamblyn R, Mayo N, Meguerditchian AN. J Geriatr Oncol. 2018 May;9(3):204-213. doi: 10.1016/j.jgo.2017.10.003. Epub 2017 Nov 28.

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study2021-07-29T22:37:51+02:00

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper

2021-07-29T22:37:52+02:00

Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NML, Baldini C, Rodrigues M, Lichtman SM, Wildiers H. J Oncol Pract. 2018 Feb;14(2):85-94. doi: 10.1200/JOP.2017.026435.

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper2021-07-29T22:37:52+02:00

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group

2021-07-29T22:37:52+02:00

Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E. Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9.

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group2021-07-29T22:37:52+02:00
Go to Top